mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.02 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.03 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.03 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.04 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.13 |
0.04 |